These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
83 related items for PubMed ID: 29260773
1. [The clinical and microbiological characteristics of oropharyngeal candidiasis in the HIV-infected patients at the late stages of the disease]. Charushin AO, Elovikov AM, Charushina IP, Vorob'eva NN, Katretskaya GG. Vestn Otorinolaringol; 2017; 82(6):7-10. PubMed ID: 29260773 [Abstract] [Full Text] [Related]
4. [New opportunities for complex treatment of oropharyngeal candidiasis in HIV-infected patients in the later stages of the disease]. Charushin AO, Elovikov AM, Charushina IP. Ter Arkh; 2023 Feb 24; 95(1):52-56. PubMed ID: 37167115 [Abstract] [Full Text] [Related]
6. Clinical and mycological responses to fluconazole and fluconazole MIC in oropharyngeal candidiasis in HIV-infected patients. Bussaratid V, Tansupasawasdikul S, Simpson A, Pitisuttithum P, Phonrat B, Howe P, White NJ. J Med Assoc Thai; 2002 Jul 24; 85(7):757-64. PubMed ID: 12296406 [Abstract] [Full Text] [Related]
7. Use of sargramostim (rh-GM-CSF) as adjunctive treatment of fluconazole-refractory oropharyngeal candidiasis in patients with AIDS: a pilot study. Vazquez JA, Hidalgo JA, De Bono S. HIV Clin Trials; 2000 Jul 24; 1(3):23-9. PubMed ID: 11590502 [Abstract] [Full Text] [Related]
8. A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS. Vazquez JA, Skiest DJ, Nieto L, Northland R, Sanne I, Gogate J, Greaves W, Isaacs R. Clin Infect Dis; 2006 Apr 15; 42(8):1179-86. PubMed ID: 16575739 [Abstract] [Full Text] [Related]
9. Oropharyngeal Candidiasis in Palliative Care Patients in Denmark. Astvad K, Johansen HK, Høiby N, Steptoe P, Ishøy T. J Palliat Med; 2015 Nov 15; 18(11):940-4. PubMed ID: 26270132 [Abstract] [Full Text] [Related]
10. Multiple oral Candida infections in patients with Sjogren's syndrome -- prevalence and clinical and drug susceptibility profiles. Yan Z, Young AL, Hua H, Xu Y. J Rheumatol; 2011 Nov 15; 38(11):2428-31. PubMed ID: 21844143 [Abstract] [Full Text] [Related]
11. Oral microflora and their relation to risk factors in HIV+ patients with oropharyngeal candidiasis. Sharifzadeh A, Khosravi AR, Shokri H, Asadi Jamnani F, Hajiabdolbaghi M, Ashrafi Tamami I. J Mycol Med; 2013 Jun 15; 23(2):105-12. PubMed ID: 23721997 [Abstract] [Full Text] [Related]
12. [Oropharyngeal candidiasis resistant to fluconazole in patients infected by HIV]. Drobacheff C, Manteaux A, Millon L, Reboux G, Barale T, Laurent R. Ann Dermatol Venereol; 1996 Jun 15; 123(2):85-9. PubMed ID: 8761757 [Abstract] [Full Text] [Related]
13. In vitro activity of voriconazole against Mexican oral yeast isolates. Sánchez Vargas LO, Eraso E, Carrillo-Muñoz AJ, Aguirre JM, Gaitán-Cepeda LA, Quindós G. Mycoses; 2010 May 15; 53(3):200-3. PubMed ID: 19389066 [Abstract] [Full Text] [Related]
14. Fluconazole-resistant pseudomembranous oral candidiasis. Shetty K. Ann Pharmacother; 2006 May 15; 40(5):993. PubMed ID: 16638917 [No Abstract] [Full Text] [Related]
16. Oral Candida isolates among HIV-infected subjects in Nigeria. Nweze EI, Ogbonnaya UL. J Microbiol Immunol Infect; 2011 Jun 15; 44(3):172-7. PubMed ID: 21524610 [Abstract] [Full Text] [Related]